Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

2008 ◽  
Vol 18 (4) ◽  
pp. 274-278 ◽  
Author(s):  
Axel Hauschild ◽  
Uwe Trefzer ◽  
Claus Garbe ◽  
Katharina C. Kaehler ◽  
Selma Ugurel ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Multicenter Phase ◽  
Deacetylase Inhibitor

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor

scholarly journals A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low‐Grade Neuroendocrine Tumors

2016 ◽  
Vol 21 (7) ◽  
pp. 785 ◽  
Author(s):  
Ning Jin ◽  
Sam J. Lubner ◽  
Daniel L. Mulkerin ◽  
Saurabh Rajguru ◽  
Lakeesha Carmichael ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Neuroendocrine Tumors ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Low Grade ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document